| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |